Antiviral usage for H1N1 treatment: Pros, cons and an argument for broader prescribing guidelines in the United States

PLoS Currents

Volumn , Issue NOV, 2009, Pages

  Lipsitch, Marc ^b   Goldstein, Edward ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873381418     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.RRN1122     Document Type: Article

References (29)

1. Aoki FY, Macleod MD, Paggiaro P, Carewicz O, El Sawy A, Wat C, Griffiths M, Waalberg E, Ward P, IMPACT Study Group: Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob. Chemother. 2003; 51(1) 123-9
2. Burch J, Corbett M, Stock C, Nicholson K, Elliot AJ, Duffy S, Westwood M, Palmer S, Stewart L: Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis. 2009 Aug 7. [Epub ahead of print] PubMed PMID: 19665930
3. McClellan K, Perry CM, Oseltamivir: a review of its use in influenza. Drugs. 2001;61(2):263-83.
4. Goldstein E, Cowling B, O'Hagan J, Danon L, Fang V, Hagy A, Miller JC, Reshef D, Robins J, Biedrzycki P, Lipsitch M. Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009, Submitted.
5. Halloran, EM, Hayden FG, Yang Y, Longini IM, Monto AS: Antiviral Effects on Influenza Viral Transmission and Pathogenicity: Observations from Household-based Trials. Amer. J Epidem. 2007 165(2):212-221
6. Ng S, Cowling BJ, Fang VJ, Chan KH, Ip DKM, Cheng CKY, Uyeki TM, Houck PM, Peiris JSM, Leung GM. Effects of oseltamivir treatment on duration of clinical illness and viral shedding, and household transmission of influenza virus. Clinical infectious Diseases, 2009 (in press).
7. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med. 2003 Jul 28;163(14):1667-72.
8. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009. N Engl J Med 2009 Oct 8.
9. Ministerio de Salud, Chile. Influenza pandemica (H1N1) 2009, FECHA: 19/08/09
10. Ministerio de Salud, Chile. Influenza pandemica (H1N1) 2009. REPORTE 21 DE OCTUBRE DE
11. Ministerio de Salud de la Nacion, Republica Argentina. Influenza pandemica (H1N1) 2009.
12. Ministerio de Salud de la Nacion, Republica Argentina. Influenza pandemica (H1N1) 2009.
13. Goldstein E, Miller JC, O'Hagan J, Lipsitch M. Predispensing of Antivirals to High-Risk Individuals in an Influenza Pandemic. PLOS Currents Influenza. Submitted.
14. CDC. Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season.
15. CNN. Oct. 13, 2009 Study: Underlying conditions playing less of role in H1N1
16. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med2009 Aug 13;361(7):680-9.
17. Rello J, Rodriguez A, Ibanez P, Socias L, Cebrian J, Marques A, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care2009 Sep 11;13(5):R148.
18. H1N1 leading to increased flu rates, more pediatric deaths.
19. CBS News. Emotional Plea from H1N1 Victim's Parents. Sep. 30, 2009
20. CDC. A weekly influenza surveillance report prepared by the influenza division
21. Health Protection Agency (UK). 26 October, 2009. Summary of prescribing guidance for the treatment and prophylaxis of influenza like illness.
22. Weekly pandemic flu media update. Health Protection Agency. 22 October 2009
23. Lipsitch M, Cohen T, Murray M, Levin BR (2007) Antiviral Resistance and the Control of Pandemic Influenza. PLoS Med 4(1): e15.
24. Wu JT, Leung GM, Lipsitch M, Cooper BS, Riley S (2009) Hedging against Antiviral Resistance during the Next Influenza Pandemic Using Small Stockpiles of an Alternative Chemotherapy. PLoS Med 6(5): e1000085.
25. Baker MG, Wilson N, Huang QS, Paine S, Lopez L, Bandaranayake D, Tobias M, Mason K, Mackereth GF, Jacobs M, Thornley C, Roberts S, McArthur C. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill. 2009;14(34):pii=19319.
26. Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis [serial on the Internet] 2009 Dec
27. Presanis AM, Lipsitch M: The severity of pandemic H1N1 influenza in the United States, April-July 2009
28. Metzger KB, Hajat A, Crawford M, Mostashari F (2004) How many illnesses does one emergency department visit represent? Using a population-based telephone survey to estimate the syndromic multiplier. MMWR Morb Mortal Wkly Rep 53 Suppl: 106-111
29. CDC. Antiviral Agents for Seasonal Influenza: Side Effects and Adverse reactions.